Author

Mélissa Saichi

Centre National de la Recherche ScientifiqueORCID 0000-0001-6461-1482Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Céline VallotiD· 2 shared Elisabetta MarangoniiD· 2 shared Gregoire JouaultiD· 2 shared Justine MarsolieriD· 2 shared Adeline DurandiD· 1 shared Ahmed DahmaniiD· 1 shared Alexandra Van KeymeuleniD· 1 shared Amélie Viaene· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Céline VallotORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsbioRxivPreprintFeb 17, 2026

Matched single-cell chromatin, transcriptome, and surface marker profiling captures in vivo epigenomic reprogramming during basal-to-luminal transition in the mammary gland

Anna A. Karpukhina, Eve Moutaux, Adeline Durand…·Céline Vallot

The paper introduces OneCell CUT&Tag, a single-cell multi-omics method that captures chromatin, transcriptome, and surface marker data, revealing epigenomic reprogramming during mammary gland basal-to-luminal transition.

DOI 10.64898/2026.02.16.706078

mousescATAC-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 17, 2025

Identification of a shared persistence program in triple-negative breast cancer across treatments and patients

Léa Baudre, Grégoire Jouault, Pacôme Prompsy…·Céline Vallot

The paper identifies a shared persistence program in triple-negative breast cancer across treatments and patients, revealing key drivers and mechanisms of drug resistance.

DOI 10.1101/2025.03.17.643634

mousebulk RNA-seq

𝕏 PostBluesky